May 18, 2022
FDA Breakthrough Device Designation for JointMedica's Polymotion® Hip Resurfacing System
JointMedica is delighted to announce that our Polymotion® Hip Resurfacing System has been granted FDA Breakthrough Device Designation.
Terry Smith, Managing Director said " This designation by the FDA is a validation of our core belief at JointMedica — that our hip resurfacing device addresses an acute unmet need of relatively younger, active hip arthritis patients"
We would like to give special thanks to our friends at MCRA for assisting us with this process (https://www.mcra.com)
Click below for the full press release: